Trade JnJ ^JNJ

Why Johnson & Johnson Is Rebounding - Finally - Yahoo News Canada

Johnson & Johnson (JNJ) Benefits from Growth Pipeline and Strength Across Key Therapeutic Areas

Jim Cramer Highlights Johnson & Johnson Stock's "Free Fall" and Rise Despite Lawsuits

Here's Why You Don't Bet Against This Dividend King

Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss

Wedge Capital Management L L P NC Lowers Holdings in Johnson & Johnson $JNJ

Chesley Taft & Associates LLC Buys 14,776 Shares of Johnson & Johnson $JNJ

Hunter Perkins Capital Management LLC Sells 22,056 Shares of Johnson & Johnson $JNJ - Daily Political

JNJ - Johnson & Johnson (JNJ): The $100 Billion Revenue Frontier and the MedTech Evolution

Johnson & Johnson's JNJ-4804 Deal Adds Weight To Immunology Story

Iran Conflict Rattles Stocks - Jim Cramer's Game Plan and 9 Stock Calls

Healthcare Stocks To Keep An Eye On - March 30th - Daily Political

Johnson Bixby & Associates LLC Buys 102,219 Shares of Schwab Fundamental Emerging Markets Equity ETF $FNDE - Markets Daily

Johnson & Johnson $JNJ Shares Sold by Pallas Capital Advisors LLC

Global X Japan Co. Ltd. Has $15.96 Million Stake in Johnson & Johnson $JNJ

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

TABR Capital Management LLC Buys New Shares in Johnson & Johnson $JNJ

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

Exchange Traded Concepts LLC Decreases Stake in Johnson & Johnson $JNJ

CoreCap Advisors LLC Boosts Stake in Johnson & Johnson $JNJ

Capital Investment Advisors LLC Increases Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Stock Position Trimmed by Avity Investment Management Inc.

NANOBIOTIX annonce la présentation des premières données de l'étude de phase 2 randomisée évaluant JNJ-1900 (NBTXR3) dans le cancer du poumon inopérable de stade III

Johnson And Johnson's Darzalex Home Use Approval Reshapes Myeloma Care Narrative

Johnson Bixby & Associates LLC Has $20 Million Stake in Capital Group Core Plus Income ETF $CGCP - Daily Political

Does J&J-Backed MRT-2359 Prostate Cancer Trial Change The Bull Case For Monte Rosa Therapeutics (GLUE)? - Simply Wall St News

Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma

Best Medical Stocks To Follow Today - March 29th - Markets Daily

J&J announces new long-term 52-week data from Phase 3 Iconic-Advance 1, 2 | Markets Insider

Top Healthcare Stocks To Keep An Eye On - March 29th - Stock Observer

Synergy Asset Management LLC Lowers Stake in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ is Fort Washington Investment Advisors Inc. OH's 10th Largest Position

Johnson & Johnson $JNJ Position Boosted by Kathmere Capital Management LLC - Markets Daily

Peak Financial Advisors LLC Buys 8,907 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Sold by Synergy Asset Management LLC - Stock Observer

Johnson & Johnson $JNJ Shares Sold by Ferguson Wellman Capital Management Inc. - Stock Observer

Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis

The Bull Case For Johnson & Johnson (JNJ) Could Change Following New ICOTYDE Phase 3 Data - Learn Why - Simply Wall St News

A Look At Monte Rosa Therapeutics (GLUE) Valuation After Johnson & Johnson MRT-2359 Trial Supply Agreement - Simply Wall St News

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

Best Healthcare Stocks To Follow Now - March 28th - Stock Observer

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Medical Stocks Worth Watching - March 28th - Daily Political

Czech National Bank Grows Stock Position in Johnson & Johnson $JNJ

New SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting

Johnson & Johnson Oncology And Immunology Advances Test Valuation Story

Johnson & Johnson (JNJ) Price Forecast: Bull Flag Signals Strength | FXEmpire

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

CAR T-Cell Therapy Market to Hit USD 13.78 Billion by 2031, Driven by Rising Global Cancer Prevalence - Insights by Product, Target, Indication, Demographic, Region, and Competitive Landscape

Johnson & Johnson (JNJ) Valuation Check As New Psoriasis And Cancer Treatment Milestones Shape Growth Expectations - Simply Wall St News

Pensionfund Sabic Takes Position in Johnson & Johnson $JNJ

E. Ohman J or Asset Management AB Cuts Position in Johnson & Johnson $JNJ

Avanza Fonder AB Grows Stock Holdings in Johnson & Johnson $JNJ

How The Story Is Shifting For Johnson & Johnson (JNJ) As Analyst Targets Rise

Johnson & Johnson (JNJ) Gains Spot on Wolfe Favorites amid Growth Outlook

What You Need To Know Ahead of Johnson & Johnson's Earnings Release

MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results | Taiwan News | Mar. 26, 2026 20:00

Assessing Johnson & Johnson (JNJ) Valuation After Recent Gains And Kenvue Spin Off

MeiraGTx Highlights Late-Stage Gene Therapy Pipeline at RBC Ophthalmology Conference - Markets Daily

31,043 Shares in Johnson & Johnson $JNJ Bought by Clear Trail Advisors LLC

Johnson & Johnson $JNJ Shares Sold by Assenagon Asset Management S.A.

Johnson & Johnson Balances Dividend Growth Biotech Exits And Talc Risks - Simply Wall St News

Johnson & Johnson (NYSE:JNJ) Stock Price Up 2% - Time to Buy?

JNJ: Fair Outlook Balances Legal Overhang With Core Healthcare Resilience

Punitive Damages Award Worth $950 Million Overturned Against Johnson & Johnson (JNJ), $16M Talc Verdict Stands

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

Best Healthcare Stocks To Add to Your Watchlist - March 25th - Stock Observer

Johnson & Johnson Launches New TECNIS Odyssey Next-Generation Intraocular Lens in India Offering Cataract Patients Precise Vision at Every Distance in Any Lighting

Pacifica Partners Inc. Lowers Stock Holdings in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Sold by Gradient Investments LLC

Promising Medical Stocks To Follow Now - March 24th - Daily Political

Doctors' Groups Oppose Notice To Paediatrician

Johnson & Johnson Targets Procedure Growth With Bladder Cancer And Vision Advances

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

Doctors rally behind Hyderabad paediatrician facing legal notice, call it intimidation - The Hindu

Healthcare Stocks To Add to Your Watchlist - March 24th - Daily Political

Bavarian Nordic A/S - Notice Convening Annual General Meeting

Johnson & Johnson (JNJ) Advances Bladder Cancer Treatment with 89% Response Rate

Johnson & Johnson $JNJ Position Cut by Legacy Private Trust Co. - Daily Political

Hamlin Capital Management LLC Reduces Holdings in Johnson & Johnson $JNJ

Procyon Advisors LLC Has $6.56 Million Stake in Johnson & Johnson $JNJ

Johnson & Johnson mCRPC Trial Adds Layer To Oncology And Valuation Story - Simply Wall St News

Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma

Enhanced dynamic risk stratification of smoldering multiple myeloma

Influence of composition, thickness, and 2D layer coupling on electrochemical CO2 reduction

2 Safe Dividend Stocks to Buy and Hold Forever

Healthcare Stocks Worth Watching - March 23rd - Markets Daily

5 Best Most Active Stocks to Buy Right Now

Johnson & Johnson $JNJ Shares Purchased by St. Louis Financial Planners Asset Management LLC

Johnson & Johnson brings TECNIS Odyssey intraocular lens to India

Farmers Trust Co. Buys 6,233 Shares of Johnson & Johnson $JNJ

Jim Cramer on Johnson & Johnson: "It's a Textbook Slowdown Stock"